Aimed Bio Inc. (KOSDAQ:0009K0)
47,550
+1,250 (2.70%)
At close: Apr 10, 2026
Aimed Bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 212,816 | 8,977 | 1,463 | 2,872 |
Short-Term Investments | 128,840 | 62,060 | 16,618 | 3,146 |
Cash & Short-Term Investments | 341,656 | 71,037 | 18,081 | 6,018 |
Cash Growth | 380.96% | 292.89% | 200.42% | - |
Accounts Receivable | 9,471 | 459.85 | - | 45.46 |
Other Receivables | 2,871 | 459.85 | 659.65 | 388.9 |
Receivables | 12,343 | 919.7 | 659.65 | 434.36 |
Prepaid Expenses | - | 103.96 | - | - |
Other Current Assets | 1,817 | 248.91 | 68.76 | 130.83 |
Total Current Assets | 355,816 | 72,310 | 18,809 | 6,584 |
Property, Plant & Equipment | 4,208 | 2,938 | 2,353 | 2,157 |
Long-Term Investments | 4,302 | 8,162 | 220.88 | 1,305 |
Other Intangible Assets | 3,239 | 3,483 | 334.61 | 325.41 |
Long-Term Deferred Tax Assets | 13,683 | - | - | - |
Other Long-Term Assets | 21,651 | 12,080 | 714.93 | 558.24 |
Total Assets | 402,898 | 98,973 | 22,432 | 10,929 |
Accounts Payable | 4,634 | 907.27 | - | - |
Accrued Expenses | 1,821 | 363.85 | 197.61 | 63.69 |
Short-Term Debt | - | 41,449 | - | - |
Current Portion of Long-Term Debt | 639.58 | 425.57 | - | - |
Current Portion of Leases | 639.58 | 425.57 | 525.67 | 490.95 |
Current Unearned Revenue | 340.91 | 795.46 | 1,295 | 140.79 |
Other Current Liabilities | 7,982 | 2,246 | 2,404 | 227.48 |
Total Current Liabilities | 16,058 | 46,613 | 4,423 | 922.9 |
Long-Term Leases | 525.13 | - | 375.01 | 521.93 |
Other Long-Term Liabilities | 1,628 | 586.81 | 32.43 | 28.98 |
Total Liabilities | 18,211 | 47,200 | 4,830 | 1,474 |
Common Stock | 64,156 | 35,471 | 17,735 | 16,716 |
Additional Paid-In Capital | 359,272 | 17,957 | 8,979 | 4,830 |
Retained Earnings | -42,826 | -52,871 | -23,132 | -14,109 |
Comprehensive Income & Other | 4,536 | 6,164 | 3,112 | 2,007 |
Total Common Equity | 385,138 | 6,721 | 6,694 | 9,443 |
Minority Interest | 3.15 | 7.5 | 15.66 | 12.29 |
Shareholders' Equity | 385,141 | 48,177 | 17,602 | 9,456 |
Total Liabilities & Equity | 403,352 | 95,377 | 22,432 | 10,929 |
Total Debt | 1,804 | 42,300 | 900.68 | 1,013 |
Net Cash (Debt) | 339,852 | 28,737 | 17,180 | 5,006 |
Net Cash Growth | 1082.64% | 67.27% | 243.21% | - |
Net Cash Per Share | - | 415.65 | 503.02 | 149.73 |
Filing Date Shares Outstanding | - | 35.47 | 35.47 | 33.43 |
Total Common Shares Outstanding | - | 35.47 | 35.47 | 33.43 |
Working Capital | 339,758 | 25,697 | 14,386 | 5,661 |
Book Value Per Share | - | 189.47 | 188.73 | 282.47 |
Tangible Book Value | 381,899 | 3,237 | 6,360 | 9,118 |
Tangible Book Value Per Share | - | 91.27 | 179.29 | 272.73 |
Machinery | 2,712 | 2,469 | 2,329 | 1,895 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.